A bill to amend title 18, United States Code, to prohibit former employees of covered health agencies from serving on the board of entities involved in development and research of a drug, biological product, or device and from profiting from a drug, biological product, or device, and for other purposes.

Bill 118 s 4232 aims to make changes to title 18 of the United States Code in order to prevent former employees of certain health agencies from serving on the boards of entities that are involved in the development and research of drugs, biological products, or devices. The bill also seeks to prohibit these former employees from profiting from these products. The main goal of this legislation is to prevent any potential conflicts of interest that may arise from former employees using their insider knowledge and connections for personal gain in the pharmaceutical and medical device industries. This bill is designed to promote transparency and integrity in the healthcare sector.